Table 1 Components of the research question on the PICOS framework
Inclusion criteria | Exclusion criteria | |
|---|---|---|
Population (P) | Patients with early-stage non-small cell lung cancer | Patients with other primary cancers Patients with advanced lung cancer or metastasis |
Intervention (I) | Stereotactic ablative radiotherapy (SABR) | Concomitant use of chemotherapy or immunotherapy |
Comparator (C) | Other radiotherapy techniques or surgical treatments | |
Outcomes (O) | Incremental cost–effectiveness ratio (ICER), cost–benefit ratio, net benefit, other summary measures | |
Design of Study (S) | Full economic evaluation (Cost-minimization analysis, Cost–effectiveness analysis, Cost-utility analysis, or Cost–benefit analysis) | Partial economic evaluations |